Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
5(36%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
3
21%
Ph not_applicable
3
21%
Ph phase_3
2
14%
Ph early_phase_1
1
7%

Phase Distribution

1

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 2Efficacy & side effects
3(33.3%)
Phase 3Large-scale testing
2(22.2%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

5

trials recruiting

Total Trials

14

all time

Status Distribution
Active(5)
Completed(3)
Terminated(1)
Other(5)

Detailed Status

unknown5
Recruiting3
Completed3
Active, not recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
5
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (11.1%)
Phase 23 (33.3%)
Phase 32 (22.2%)
N/A3 (33.3%)

Trials by Status

recruiting321%
withdrawn17%
unknown536%
active_not_recruiting214%
completed321%

Recent Activity

5 active trials
Showing 5 of 14
recruitingphase_2

Rescue of Nephrons With ALE.F02 (RENAL-F02)

NCT06047171
active_not_recruitingphase_2

Islet Cell Transplant for Type 1 Diabetes

NCT01909245
active_not_recruitingnot_applicable

Effect of Immunosuppressants With Adalimumab Biosimilars vs Corticosteroids on Noninfectious Uveitis

NCT06310837
recruitingnot_applicable

Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease

NCT05321758
recruitingphase_3

InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease

NCT06059989
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT06047171Phase 2

Rescue of Nephrons With ALE.F02 (RENAL-F02)

Recruiting
NCT01909245Phase 2

Islet Cell Transplant for Type 1 Diabetes

Active Not Recruiting
NCT06310837Not Applicable

Effect of Immunosuppressants With Adalimumab Biosimilars vs Corticosteroids on Noninfectious Uveitis

Active Not Recruiting
NCT05321758Not Applicable

Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease

Recruiting
NCT06059989Phase 3

InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease

Recruiting
NCT03605654Phase 2

Cellular Immunotherapy in Recipients of Human Leukocyte Antigen (HLA)-Mismatched, Living Donor Kidney Transplants

Withdrawn
NCT06121804

Immunosuppressants to Postoperative Infection and Death

Unknown
NCT02416674Early Phase 1

Vascularized Composite Allotransplantation for Treatment of Abdominal Wall Defects

Unknown
NCT02294032

The Role of B Cells in Kidney Allograft Dysfunction

Completed
NCT05863936Phase 3

Trial of Belimumab Combined With Multi-target Induction Therapy in Lupus Nephritis

Unknown
NCT04568421

Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection

Completed
NCT02388802Not Applicable

Human Clinical Trial of Uterine Transplantation in the United Kingdom

Unknown
NCT01813617

Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis

Completed
NCT01613963

Causes of Visual Loss in Retinal Disease

Unknown

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14